AIXC (AIxCrypto Holdings, Inc.) Stock Financials & Earnings | Market Cap Arena

AIXC (AIxCrypto Holdings, Inc.) Stock Financials & Earnings | Market Cap Arena

AIXCAIxCrypto Holdings, Inc.

Mkt Cap$7M

Healthcare·Medical - Pharmaceuticals·🇺🇸 United States·NASDAQ

Revenue (TTM)$0

Net Income (TTM)-$7M

EPS (TTM)-$4.55

Free Cash Flow (TTM)-$7M

Gross Margin—

Op. Margin—

Net Margin—

FCF Margin—

P/S Ratio (TTM)—

P/E Ratio (TTM)—

YoY Rev Growth—

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q4 23	$0	-$1M	-$2M
Q1 24	$0	-$364K	-$1M
Q2 24	$0	-$754K	-$2M
Q3 24	$0	$0	-$1M
Q4 24	$0	$0	-$1M
Q1 25	$0	$0	-$3M
Q2 25	$0	$0	-$2M
Q3 25	$0	-$106K	-$1M

Operating Cash Flow

Quarter	Operating CF	Free CF
Q4 23	-$6M	$0
Q1 24	-$784K	-$784K
Q2 24	-$1M	-$1M
Q3 24	-$2M	-$2M
Q4 24	-$2M	-$2M
Q1 25	-$2M	-$2M
Q2 25	-$1M	-$1M
Q3 25	-$2M	-$2M

Capital Expenditures

CapEx

Quarter	CapEx
Q4 23	$6M
Q1 24	$4
Q2 24	$0
Q3 24	$0
Q4 24	$0
Q1 25	$0
Q2 25	$0
Q3 25	$0

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q4 24	—	-41.4%
Q1 25	—	+91.6%
Q2 25	—	-3.3%
Q3 25	—	+12.7%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q4 23	$0	—
Q1 24	$0	—
Q2 24	$0	—
Q3 24	$27K	—
Q4 24	$9K	—
Q1 25	$269	—
Q2 25	$0	—
Q3 25	$0	—

OpEx Breakdown

Quarter	R&D	G&A
Q4 23	$1M	$963K
Q1 24	$364K	$1M
Q2 24	$754K	$986K
Q3 24	$123K	$1M
Q4 24	—	$1M
Q1 25	$33K	$2M
Q2 25	$18K	$1M
Q3 25	$106K	$2M

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 23	$402K	$0	$402K
Q1 24	$93K	$0	$93K
Q2 24	$119K	$0	$119K
Q3 24	$388K	$0	$388K
Q4 24	$1M	$0	$1M
Q1 25	$30K	$0	$30K
Q2 25	$332K	$0	$332K
Q3 25	$39M	$0	$39M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q4 23	105K	—
Q1 24	119K	+13.7%
Q2 24	152K	+27.9%
Q3 24	388K	+155.1%
Q4 24	0	-100.0%
Q1 25	1M	—
Q2 25	2M	+15.6%
Q3 25	2M	+0.0%